sciences

Gilead Could Goose Biotech ETFs

Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]

Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?

Although biotech stocks as a whole handily outpaced the S&P 500 returns last year, there’s no guarantee that investors will be similarly rewarded this year. To get insight into whether biotech stocks can continue climbing, we asked three top Motley Fool contributors to give us their opinion. Read on to learn what they think.: Bringing a new drug to market […]

3 Small-Cap Biotech Stocks That Could Be Top Stocks in 2015

Source: Flickr user stockmonkeys.com .The pop-and-drop nature of the biotech industry makes owning stocks in the sector particularly dicey. But for investors willing to take on the risk of failure, a number of intriguing small-cap biotech companies are working on important new therapies that could make a big impact on patients’ lives and investors’ wallets. Here are three of thesecompanies.No. […]

RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock …

Healthcare

RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock Trading Up

Apricus Biosciences announces on Tuesday that it has been awarded Rayva’s Patent by USPTO; stock soars by 15.58%
APRI

By: Martin BlancPublished: Jan 28, 2015 at 11:41 am EST

Apricus Biosciences Inc. (NASDAQ:APRI) is trading up by around 15.58% as of 11:14 AM EST. The buying spree on the stock followed the announcement […]

(APRI) Stock Trading Up – Bidness Etc

Healthcare

RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock Trading Up

Apricus Biosciences announces on Tuesday that it has been awarded Rayva’s Patent by USPTO; stock soars by 15.58%
APRI

By: Martin BlancPublished: Jan 28, 2015 at 11:41 am EST

Apricus Biosciences Inc. (NASDAQ:APRI) is trading up by around 15.58% as of 11:14 AM EST. The buying spree on the stock followed the announcement […]

Select 2015 Stem Cell Company Catalysts: Sagient Research’s Edward Stopke

Under agreement with StreetWise Reports, I’m pleased to share their recent coverage of the regenerative medicine sector.Original Source: Source: Peter Byrne of The Life Sciences Report (1/22/15)”Convert Catalysts into Profits: Sagient Research’s Edward Stopke“The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline […]

5 Tiny Biotech Stocks to Own in 2015

Biotech stocks are among the market’s riskiest, but investors willing to accept the potential for pipeline failure might consider owning these five small-cap biotech stocks in 2015. All five have intriguing therapies in late-stage clinical trials, and three have high-profile big-cap partners.Source: Flickr user Carlos Gracia1. Proven performerInsys Therapeutics is already rewarding shareholders with rapid sales growth and profitability, but […]

Big Short Interest On These 5 Biotech Stocks

View gallery.Rumor has it that if the S&P 500 finishes its first five trading days of the year with a gain, then the year in question will — 80 percent of the time — end with a gain as well.Last Thursday’s rally gave the S&P that five-day gain. However, since that day, the market has seen a decent amount of […]

Big Short Interest On These 5 Biotech Stocks – Benzinga

Rumor has it that if the S&P 500 finishes its first five trading days of the year with a gain, then the year in question will — 80 percent of the time — end with a gain as well.Last Thursday’s rally gave the S&P that five-day gain. However, since that day, the market has seen a decent amount of weakness.The […]

Better Healthcare Buy: Big or Little Biotechs

Source: Flickr user Chris PotterBiotechnology stocks were among the market’s top performers in 2014, but biotech stocks were also among the market’s riskiest plays. For risk tolerant investors, biotech’s pop-and-drop nature may be enticing, but should investors focus on big or small cap biotech stocks? We asked some of our top Motley Fool analysts for their opinion. Read on to […]